Skip to content
ExordiumBiotech
Powder, gel and crystalline ingredient specimens arranged for material study — illustrative imagery
Scientific research

The work before a formula exists.

Evidence review, mechanism investigation, ingredient intelligence and feasibility. Research is a standalone engagement, not a preface to something else.

Evidence review

A question, narrowed by evidence.

  1. Literature research

    Structured review of published evidence, including contradiction and uncertainty.

  2. Bioscience research

    Investigation of biological rationale relevant to the intended product.

  3. Ingredient intelligence

    Forms, grades, use levels, sourcing realities and known limitations.

  4. Mechanism investigation

    What is proposed to happen, and how well that proposition is supported.

  5. Feasibility assessment

    Whether the concept can exist as a manufacturable product.

  6. Competitive research

    Technical reading of existing products and their formulation logic.

  7. Technology landscape

    Technical orientation on the surrounding patent and technology field.

  8. Delivery systems

    Which delivery approaches suit the active and intended use.

Method

The inquiry sequence

  1. 01

    Question definition

    Agreed research scope and answerable question set.

  2. 02

    Evidence review

    Referenced findings with confidence and limitations noted.

  3. 03

    Technical assessment

    An account of what is viable and what is not.

  4. 04

    Direction

    Written research position and recommended next step.

The record

Evidence, then material reality.

Published findings are read alongside how the ingredient actually behaves — form, grade, solubility, sourcing and known limitations. A promising paper and a workable material are not the same thing.

Plain paper, a closed notebook and an empty glass vial — illustrative imagery

Boundaries

Limits belong in the record.

Exordium does not provide legal or patent counsel. Technical landscape work is orientation only; intellectual-property decisions belong with qualified attorneys.

  • No regulatory or legal advice
  • No efficacy claims
  • Testing coordinated through qualified third-party laboratories
  • Findings reported with their limitations

Start with the project as it is today

What question are you trying to answer?

Tell us where the project stands today. Every brief is reviewed for technical fit, development readiness and current laboratory capacity — you do not need all the technical answers first.

Can you research before there is a formula? →
Submit a project brief

Six short steps. No account, no pricing gate.

Or contact the laboratory directly